VC
CGON icon

VarCov Co’s CG Oncology CGON Stock Holding History

VarCov Co’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+2,994
New +$196K 0.08% 326

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VarCov Co's CGON Position: Q2 2026 in Review

VarCov Co opened a new position in CG Oncology (CGON) in Q2 2026: 2,994 shares worth $213K. The stake represents 0.08% of the portfolio and ranks #326 among its holdings.

226 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • VarCov Co held 2,994 shares of CG Oncology worth $213K as of Q2 2026.
  • CG Oncology was a new VarCov Co position in Q2 2026.
  • CG Oncology made up 0.08% of VarCov Co's portfolio in Q2 2026, its #326 holding.
  • 226 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.